Deutsche Bank’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Deutsche Bank's ICPT Position: Q4 2023 in Review

Deutsche Bank sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 14,755 shares — an estimated $274K sold.

Deutsche Bank first reported a position in ICPT in Q2 2013 and held it in 42 quarters. The position peaked at $61.1M in Q3 2018. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

• Deutsche Bank reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
• Deutsche Bank sold 14,755 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $274K.
• Deutsche Bank first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 42 quarters.
• Deutsche Bank's Intercept Pharmaceuticals, Inc. position peaked at $61.1M in Q3 2018.
• 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Deutsche Bank's 13F filing for Q4 2023, filed 14 Feb 2024.